Literature DB >> 22472957

Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma.

Aatur D Singhi1, Audrey J Lazenby, Elizabeth A Montgomery.   

Abstract

Gastric adenocarcinoma with chief cell differentiation (GA-CCD) has been reported as a new, rare variant of gastric adenocarcinoma. Only 12 cases in Japanese patients have been described to date, but they demonstrate distinct clinicopathologic features. To further characterize these lesions, we have collected 10 additional cases. Patients ranged in age from 44 to 79 years (mean, 64.2 y) with a relatively equal sex distribution (6 women and 4 men). Stratified by race, 4 patients were Hispanic, 2 were White, 2 were African American, 1 was Asian (Chinese), and the race was unknown for 1 patient. All patients presented with gastroesophageal reflux that prompted an endoscopic examination. The majority of GA-CCDs were identified in the fundus (7 of 10, 70%) and the remaining in the cardia (n=3). Grossly, they were solitary and polypoid, ranging in size from 0.2 to 0.8 cm (mean, 0.4 cm). Histologically, all cases were centered in the deep mucosa, with focal involvement of surface foveolar epithelium in 3 (30%) cases but not the submucosa. The tumors consisted of clustered glands and irregular branching cords of oxyntic epithelium. Thin wisps of radiating smooth muscle separated the epithelium, but desmoplasia was distinctly absent in all cases. The oxyntic mucosa was 1 to 2 cells thick and composed of a mixture of mucous neck, parietal, and chief cells. In 7 of 10 (70%) cases, chief cells were the predominant cell type, whereas the remaining 3 cases consisted primarily of mucous neck cells. The nuclei were mildly enlarged with slight nuclear pleomorphism, but no mitotic figures were identified. In addition, necrosis, lymphovascular invasion, and perineural invasion were absent. Immunohistochemically, GA-CCDs were diffusely positive for MUC6 (10 of 10, 100%) and negative for MUC5AC (0%) and MUC2 (0%). Ki-67 immunolabeling demonstrated variable expression, with the highest areas ranging from 0.2% to 10%. Clinical follow-up was available for 9 of 10 (90%) patients and ranged from 6 to 39 months. One patient had persistence of lesion at 6 months because of incomplete removal, whereas the other 8 were disease free. In summary, GA-CCDs are solitary, mucosal lesions of the gastric cardia/fundus that arise in patients from multiple ethnic backgrounds. Considering that patients within this study and those reported previously have had neither true recurrence nor progression of disease, these lesions are best regarded as benign. Consequently, the term GA-CCD is contradictory and we prefer the descriptive term "oxyntic gland polyp/adenoma" until further studies can clarify the pathogenesis of these lesions and their natural history.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472957     DOI: 10.1097/PAS.0b013e31825033e7

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  21 in total

1.  Gastric adenocarcinoma of fundic gland type: Five cases treated with endoscopic resection.

Authors:  Masaki Miyazawa; Mitsuru Matsuda; Masaaki Yano; Yasumasa Hara; Fumitaka Arihara; Yosuke Horita; Koichiro Matsuda; Akito Sakai; Yatsugi Noda
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  A Rare Case of Gastric Fundic Gland Adenocarcinoma (Chief Cell Predominant Type).

Authors:  Wei-Chung Chen; Paul M Rodriguez-Waitkus; Alberto Barroso; Ashok Balsaver; John C McKechnie
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Mutation spectrum in the Wnt/β-catenin signaling pathway in gastric fundic gland-associated neoplasms/polyps.

Authors:  Se-Yong Lee; Tsuyoshi Saito; Hiroyuki Mitomi; Yasuhiro Hidaka; Takashi Murakami; Ryosuke Nomura; Sumio Watanabe; Takashi Yao
Journal:  Virchows Arch       Date:  2015-03-29       Impact factor: 4.064

4.  Oxyntic gland adenoma endoscopically mimicking a gastric neuroendocrine tumor: A case report.

Authors:  Tae-In Lee; Jae-Young Jang; Seungmin Kim; Jung-Wook Kim; Young-Woon Chang; Youn-Wha Kim
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  Gastric adenocarcinoma of fundic gland type: Endoscopic and clinicopathological features.

Authors:  Gen Tohda; Takeshi Osawa; Yasuyuki Asada; Masaki Dochin; Shintarou Terahata
Journal:  World J Gastrointest Endosc       Date:  2016-02-25

6.  Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis.

Authors:  Wenzel M Hackeng; Elizabeth A Montgomery; Francis M Giardiello; Aatur D Singhi; Marija Debeljak; James R Eshleman; Michael Vieth; G Johan Offerhaus; Laura D Wood; Lodewijk A A Brosens
Journal:  Histopathology       Date:  2016-12-13       Impact factor: 5.087

7.  Gastric Fundic Gland Adenocarcinoma With Chief Cell Differentiation.

Authors:  Neil D Parikh; Joanna Gibson; Harry Aslanian
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-26       Impact factor: 11.382

8.  Cell polarity (the 'four lines') distinguishes gastric dysplasia from epithelial changes in reactive gastropathy.

Authors:  Kevin M Waters; Kevan J Salimian; Naziheh Assarzadegan; Danielle Hutchings; Elias P Makhoul; Annika L Windon; Mary T Wong; Lysandra Voltaggio; Elizabeth A Montgomery
Journal:  Histopathology       Date:  2020-10-14       Impact factor: 7.778

9.  Concurrent Gastric Adenocarcinoma of Fundic Gland Type and Carcinoma with Lymphoid Stroma: A Rare Case Report.

Authors:  Hee Jeong Cha; Kyungbin Kim; Misung Kim; Hyejeong Choi; Young Min Kim; Jae Hee Suh
Journal:  Case Rep Gastroenterol       Date:  2016-06-14

10.  Twelve-year natural history of a gastric adenocarcinoma of fundic gland type.

Authors:  Yoshinori Sato; Takashi Fujino; Akira Kasagawa; Ryo Morita; Shun-Ichiro Ozawa; Yasumasa Matsuo; Tadateru Maehata; Hiroshi Yasuda; Masayuki Takagi; Fumio Itoh
Journal:  Clin J Gastroenterol       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.